Acceptance and Effectiveness of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2) Vaccination in Systemic Sclerosis Patients Treated by Autologous Hematopoietic Stem Cell Transplantation
Clinical trial NCT05960058 · UNKNOWN
Trial details
- NCT number
- NCT05960058
- Sponsor
- Assistance Publique - Hôpitaux de Paris
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2023-07-01
- Primary completion
- 2024-07-01
- Enrollment
- 72
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.